Business Description
PuraPharm Corporation Ltd
ISIN : KYG7306Y1044
Share Class Description:
HKSE:01498: Shs Reg STotal Employee Number:
469Compare
Compare
Traded in other countries / regions
01498.Hong Kong IPO Date
2015-07-08Description
PuraPharm Corporation Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, production, and sale of concentrated Chinese medicine granules (CCMG) and other Chinese healthcare products. Its operations also include the cultivation and trading of raw Chinese herbs, the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces, and the provision of Chinese medical diagnostic services. The Group's reportable operating segments are: China CCMG, Hong Kong CCMG, Chinese healthcare products, Clinics, and Plantation. Maximum revenue is derived from the Hong Kong CCMG segment. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from the Chinese Mainland and other countries.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 2.69 | |||||
Debt-to-EBITDA | 11.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.17 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.9 | |||||
3-Year EPS without NRI Growth Rate | 28.6 | |||||
3-Year FCF Growth Rate | -28.2 | |||||
3-Year Book Growth Rate | -27.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.33 | |||||
9-Day RSI | 46.06 | |||||
14-Day RSI | 45.4 | |||||
3-1 Month Momentum % | -3.33 | |||||
6-1 Month Momentum % | -13.43 | |||||
12-1 Month Momentum % | -36.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.47 | |||||
Quick Ratio | 0.27 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 238.79 | |||||
Days Sales Outstanding | 103.38 | |||||
Days Payable | 262.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.6 | |||||
Shareholder Yield % | 16.34 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.6 | |||||
Operating Margin % | -6.66 | |||||
Net Margin % | -10.48 | |||||
EBITDA Margin % | 9.18 | |||||
FCF Margin % | 7.64 | |||||
OCF Margin % | 8.49 | |||||
ROE % | -30.78 | |||||
ROA % | -5.06 | |||||
ROIC % | -3.03 | |||||
3-Year ROIIC % | -12.07 | |||||
ROC (Joel Greenblatt) % | -3.45 | |||||
ROCE % | -6.13 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.35 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 3.11 | |||||
Price-to-Free-Cash-Flow | 4.24 | |||||
Price-to-Operating-Cash-Flow | 3.83 | |||||
EV-to-EBIT | -35.42 | |||||
EV-to-Forward-EBIT | 17.16 | |||||
EV-to-EBITDA | 15.72 | |||||
EV-to-Revenue | 1.44 | |||||
EV-to-Forward-Revenue | 0.83 | |||||
EV-to-FCF | 18.87 | |||||
Price-to-GF-Value | 0.55 | |||||
Price-to-Projected-FCF | 0.24 | |||||
Price-to-Median-PS-Value | 0.49 | |||||
Earnings Yield (Greenblatt) % | -2.82 | |||||
FCF Yield % | 17.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PuraPharm Corporation Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 336.113 | ||
| EPS (TTM) (HK$) | -0.084 | ||
| Beta | 0.2544 | ||
| 3-Year Sharpe Ratio | -1.53 | ||
| 3-Year Sortino Ratio | -1.8 | ||
| Volatility % | 17.76 | ||
| 14-Day RSI | 45.4 | ||
| 14-Day ATR (HK$) | 0.008336 | ||
| 20-Day SMA (HK$) | 0.2825 | ||
| 12-1 Month Momentum % | -36.26 | ||
| 52-Week Range (HK$) | 0.27 - 0.465 | ||
| Shares Outstanding (Mil) | 535.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PuraPharm Corporation Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PuraPharm Corporation Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PuraPharm Corporation Ltd Frequently Asked Questions
What is PuraPharm Corporation Ltd(HKSE:01498)'s stock price today?
The current price of HKSE:01498 is HK$0.28. The 52 week high of HKSE:01498 is HK$0.47 and 52 week low is HK$0.27.
When is next earnings date of PuraPharm Corporation Ltd(HKSE:01498)?
The next earnings date of PuraPharm Corporation Ltd(HKSE:01498) is .
Does PuraPharm Corporation Ltd(HKSE:01498) pay dividends? If so, how much?
PuraPharm Corporation Ltd(HKSE:01498) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on PuraPharm Corporation Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers